title: Thyrotropin receptor and membrane interactions in FRTL-5 thyroid cell strain in microgravity.
abstract: The aim of this work was to analyze the possible alteration of thyrotropin (TSH) receptors in microgravity, which could explain the absence of thyroid cell proliferation in the space environment. Several forms of the TSH receptor are localized on the plasma membrane associated with caveolae and lipid rafts. The TSH regulates the fluidity of the cell membrane and the presence of its receptors in microdomains that are rich in sphingomyelin and cholesterol. TSH also stimulates cyclic adenosine monophosphate (cAMP) accumulation and cell proliferation. Reported here are the results of an experiment in which the FRTL-5 thyroid cell line was exposed to microgravity during the Texus-44 mission (launched February 7, 2008, from Kiruna, Sweden). When the parabolic flight brought the sounding rocket to an altitude of 264 km, the culture media were injected with or without TSH in the different samples, and weightlessness prevailed on board for 6 minutes and 19 seconds. Control experiments were performed, in parallel, in an onboard 1g centrifuge and on the ground in Kiruna laboratory. Cell morphology and function were analyzed. Results show that in microgravity conditions the cells do not respond to TSH treatment and present an irregular shape with condensed chromatin, a modification of the cell membrane with shedding of the TSH receptor in the culture medium, and an increase of sphingomyelin-synthase and Bax proteins. It is possible that real microgravity induces a rearrangement of specific sections of the cell membrane, which act as platforms for molecular receptors, thus influencing thyroid cell function in astronauts during space missions.
authors.affiliation: Department of Clinical and Experimental Medicine, University School of Medicine, Perugia, Italy. ealbi@unipg.it
authors.forename: E
authors.initials: E
authors.lastname: Albi
authors.forename: F S
authors.initials: FS
authors.lastname: Ambesi-Impiombato
authors.forename: M
authors.initials: M
authors.lastname: Peverini
authors.forename: E
authors.initials: E
authors.lastname: Damaskopoulou
authors.forename: E
authors.initials: E
authors.lastname: Fontanini
authors.forename: R
authors.initials: R
authors.lastname: Lazzarini
authors.forename: F
authors.initials: F
authors.lastname: Curcio
authors.forename: G
authors.initials: G
authors.lastname: Perrella
mesh_terms: D002460:Cell Line; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism*; D002467:Cell Nucleus / Q000187:drug effects / Q000378:metabolism; D048430:Cell Shape / Q000187:drug effects; D002784:Cholesterol / Q000378:metabolism; D003470:Culture Media / Q000737:chemistry; D000242:Cyclic AMP / Q000378:metabolism; D006801:Humans; D011419:Propidium / Q000378:metabolism; D011989:Receptors, Thyrotropin / Q000378:metabolism*; D013026:Space Flight; D013109:Sphingomyelins / Q000378:metabolism; D013961:Thyroid Gland / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D013972:Thyrotropin / Q000494:pharmacology; D014893:Weightlessness
chemical_list: D003470:Culture Media; D011989:Receptors, Thyrotropin; D013109:Sphingomyelins; D011419:Propidium; D013972:Thyrotropin; D002784:Cholesterol; D000242:Cyclic AMP